Global Insomnia Therapy Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Insomnia Therapy Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Insomnia Therapy Market Size Growth Rate by Product
- 1.4.2 Non-pharmacological Therapy
- 1.4.3 Pharmacological Therapy
- 1.5 Market by End User
- 1.5.1 Global Insomnia Therapy Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Ambulatory Surgical Center
- 1.5.4 Home Care
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Insomnia Therapy Market Size
- 2.1.1 Global Insomnia Therapy Revenue 2014-2025
- 2.1.2 Global Insomnia Therapy Sales 2014-2025
- 2.2 Insomnia Therapy Growth Rate by Regions
- 2.2.1 Global Insomnia Therapy Sales by Regions
- 2.2.2 Global Insomnia Therapy Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Insomnia Therapy Sales by Manufacturers
- 3.1.1 Insomnia Therapy Sales by Manufacturers
- 3.1.2 Insomnia Therapy Sales Market Share by Manufacturers
- 3.1.3 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
- 3.2 Insomnia Therapy Revenue by Manufacturers
- 3.2.1 Insomnia Therapy Revenue by Manufacturers (2014-2019)
- 3.2.2 Insomnia Therapy Revenue Share by Manufacturers (2014-2019)
- 3.3 Insomnia Therapy Price by Manufacturers
- 3.4 Insomnia Therapy Manufacturing Base Distribution, Product Types
- 3.4.1 Insomnia Therapy Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Insomnia Therapy Product Type
- 3.4.3 Date of International Manufacturers Enter into Insomnia Therapy Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Insomnia Therapy Sales by Product
- 4.2 Global Insomnia Therapy Revenue by Product
- 4.3 Insomnia Therapy Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Insomnia Therapy Breakdown Data by End User
6 North America
- 6.1 North America Insomnia Therapy by Countries
- 6.1.1 North America Insomnia Therapy Sales by Countries
- 6.1.2 North America Insomnia Therapy Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Insomnia Therapy by Product
- 6.3 North America Insomnia Therapy by End User
7 Europe
- 7.1 Europe Insomnia Therapy by Countries
- 7.1.1 Europe Insomnia Therapy Sales by Countries
- 7.1.2 Europe Insomnia Therapy Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Insomnia Therapy by Product
- 7.3 Europe Insomnia Therapy by End User
8 Asia Pacific
- 8.1 Asia Pacific Insomnia Therapy by Countries
- 8.1.1 Asia Pacific Insomnia Therapy Sales by Countries
- 8.1.2 Asia Pacific Insomnia Therapy Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Insomnia Therapy by Product
- 8.3 Asia Pacific Insomnia Therapy by End User
9 Central & South America
- 9.1 Central & South America Insomnia Therapy by Countries
- 9.1.1 Central & South America Insomnia Therapy Sales by Countries
- 9.1.2 Central & South America Insomnia Therapy Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Insomnia Therapy by Product
- 9.3 Central & South America Insomnia Therapy by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Insomnia Therapy by Countries
- 10.1.1 Middle East and Africa Insomnia Therapy Sales by Countries
- 10.1.2 Middle East and Africa Insomnia Therapy Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Insomnia Therapy by Product
- 10.3 Middle East and Africa Insomnia Therapy by End User
11 Company Profiles
- 11.1 Merck & Co. Inc.
- 11.1.1 Merck & Co. Inc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck & Co. Inc. Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck & Co. Inc. Insomnia Therapy Products Offered
- 11.1.5 Merck & Co. Inc. Recent Development
- 11.2 Sanofi
- 11.2.1 Sanofi Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sanofi Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sanofi Insomnia Therapy Products Offered
- 11.2.5 Sanofi Recent Development
- 11.3 Pfizer, Inc.
- 11.3.1 Pfizer, Inc. Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer, Inc. Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer, Inc. Insomnia Therapy Products Offered
- 11.3.5 Pfizer, Inc. Recent Development
- 11.4 Takeda Pharmaceutical Company Ltd.
- 11.4.1 Takeda Pharmaceutical Company Ltd. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Products Offered
- 11.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
- 11.5 Purdue Pharmaceuticals L.P.
- 11.5.1 Purdue Pharmaceuticals L.P. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Products Offered
- 11.5.5 Purdue Pharmaceuticals L.P. Recent Development
- 11.6 Eisai, Co. Ltd.
- 11.6.1 Eisai, Co. Ltd. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Eisai, Co. Ltd. Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Eisai, Co. Ltd. Insomnia Therapy Products Offered
- 11.6.5 Eisai, Co. Ltd. Recent Development
- 11.7 Meda Consumer Healthcare Inc.
- 11.7.1 Meda Consumer Healthcare Inc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Meda Consumer Healthcare Inc. Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Meda Consumer Healthcare Inc. Insomnia Therapy Products Offered
- 11.7.5 Meda Consumer Healthcare Inc. Recent Development
- 11.8 Pernix Therapeutics
- 11.8.1 Pernix Therapeutics Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pernix Therapeutics Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pernix Therapeutics Insomnia Therapy Products Offered
- 11.8.5 Pernix Therapeutics Recent Development
- 11.9 Vanda Pharmaceuticals
- 11.9.1 Vanda Pharmaceuticals Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Vanda Pharmaceuticals Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Vanda Pharmaceuticals Insomnia Therapy Products Offered
- 11.9.5 Vanda Pharmaceuticals Recent Development
- 11.10 ECR Pharmaceuticals
- 11.10.1 ECR Pharmaceuticals Company Details
- 11.10.2 Company Business Overview
- 11.10.3 ECR Pharmaceuticals Insomnia Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 ECR Pharmaceuticals Insomnia Therapy Products Offered
- 11.10.5 ECR Pharmaceuticals Recent Development
- 11.11 Fidia Farmaceutici
- 11.12 Dainippon Sumitomo
- 11.13 Biocodex
- 11.14 Eli Lilly and Company
- 11.15 Ebb Therapeutics
12 Future Forecast
- 12.1 Insomnia Therapy Market Forecast by Regions
- 12.1.1 Global Insomnia Therapy Sales Forecast by Regions 2019-2025
- 12.1.2 Global Insomnia Therapy Revenue Forecast by Regions 2019-2025
- 12.2 Insomnia Therapy Market Forecast by Product
- 12.2.1 Global Insomnia Therapy Sales Forecast by Product 2019-2025
- 12.2.2 Global Insomnia Therapy Revenue Forecast by Product 2019-2025
- 12.3 Insomnia Therapy Market Forecast by End User
- 12.4 North America Insomnia Therapy Forecast
- 12.5 Europe Insomnia Therapy Forecast
- 12.6 Asia Pacific Insomnia Therapy Forecast
- 12.7 Central & South America Insomnia Therapy Forecast
- 12.8 Middle East and Africa Insomnia Therapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Insomnia Therapy Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
The global Insomnia Therapy market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insomnia Therapy market based on company, product type, end user and key regions.
This report studies the global market size of Insomnia Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insomnia Therapy in these regions.
This research report categorizes the global Insomnia Therapy market by top players/brands, region, type and end user. This report also studies the global Insomnia Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck & Co. Inc.
Sanofi
Pfizer, Inc.
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare Inc.
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Market size by Product
Non-pharmacological Therapy
Pharmacological Therapy
Market size by End User
Hospital
Ambulatory Surgical Center
Home Care
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Insomnia Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Insomnia Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Insomnia Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Insomnia Therapy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Insomnia Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insomnia Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.